Previous study has shown that the mRNA and protein expression of FTO were upregulated in non-alcoholic fatty liver disease (NAFLD) rats, which were involved in lipid metabolism disorders [39]. This evidence concerns the gene FTO and metabolic dysfunction-associated steatotic liver disease.